Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇪🇺 EMA

Alzheimer's Disease Analysis

🇪🇺 EMA

Expert commentary and market intelligence for pharma strategy teams

Showing 1–2 of 2 articles

High impact AnalysisJun 2, 2026

Eisai's Leqembi Sales Forecast: Projecting Blockbuster Status in Alzheimer's

FDA · Alzheimer's · 6 min

Dr. Elena Rossi
Medium impact AnalysisMay 31, 2026

Actinogen's EMA Scientific Advice: A Positive Step for Alzheimer's Program

FDA · Alzheimer's disease · 2 min

Dr. Elena Rossi

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.